Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies

NCT00890955 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Amrubicin
DRUG: Cyclophosphamide

Sponsor

Lawrence Einhorn

Collaborators

[object Object]
[object Object]